Exopharm Limited (ASX:EX1)’s share price dropped 3.4% during mid-day trading on Friday . The stock traded as low as A$0.28 ($0.20) and last traded at A$0.28 ($0.20), approximately 79,820 shares traded hands during trading. The stock had previously closed at A$0.29 ($0.21).
The company has a fifty day simple moving average of A$0.36. The firm has a market capitalization of $26.73 million and a PE ratio of -7.00.
About Exopharm (ASX:EX1)
Exopharm Limited, a biopharmaceutical company, focuses on developing and commercializing clinical human therapeutics in Australia. It is developing Plexaris, an exosome derived from human platelets; and Exomeres, an exosome derived from adult stem cells. The company was founded in 2003 and is headquartered in Melbourne, Australia.
Further Reading: How analysts view the yield curve
Receive News & Ratings for Exopharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exopharm and related companies with MarketBeat.com's FREE daily email newsletter.